z-logo
Premium
Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma
Author(s) -
Yang Ju Dong,
Campion Michael B.,
Liu Minetta C.,
Chaiteerakij Roongruedee,
Giama Nasra H.,
Ahmed Mohammed Hager,
Zhang Xiaodan,
Hu Chunling,
Campion Victoria L.,
Jen Jin,
Venkatesh Sudhakar K.,
Halling Kevin C.,
Kipp Benjamin R.,
Roberts Lewis R.
Publication year - 2016
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.27944
Subject(s) - medicine , circulating tumor cell , hazard ratio , proportional hazards model , oncology , colorectal cancer , confidence interval , prostate cancer , gastroenterology , metastasis , survival analysis , cancer
Circulating tumor cells (CTCs) in blood are associated with poor survival of patients with breast, prostate, or colon cancer. We hypothesized that CTCs are associated with poor survival of patients with cholangiocarcinoma (CCA). Eighty‐eight patients with CCA were prospectively enrolled at Mayo Clinic Rochester between June 2010 and September 2014. The CellSearch system by Veridex was used for detection of CTCs in peripheral blood. Associations between CTC, patient and tumor characteristics, and survival were examined using the Cox's proportional hazards model. Fifteen patients (17%) were positive for CTC ≥2 and 8 patients (9%) for CTC ≥5. CTCs were associated with tumor extent. CTC ≥2 (hazard ratio [HR]: 2.5; 95% confidence interval [CI]: 1.1‐5.4; P  = 0.02) and CTC ≥5 (HR, 4.1; 95% CI: 1.4‐10.8; P  = 0.01) were both independent predictors of survival. In subgroup analyses, CTC ≥2 (HR, 8.2; 95% CI: 1.8‐57.5; P  < 0.01) and CTC ≥5 (HR, 7.7; 95% CI: 1.4‐42.9; P  = 0.02) were both associated with shorter survival among patients with metastasis. There was a trend toward association of CTC ≥5 with shorter survival in patients with nonmetastatic CCA (HR, 4.3; 95% CI: 1.0‐13.8; P  = 0.06). CTC ≥2 (HR, 10.5; 95% CI: 2.2‐40.1; P  < 0.01) and CTC ≥5 (HR, 10.2; 95% CI: 1.5‐42.3; P  = 0.02) were both associated with shorter survival among patients with perihilar/distal CCA. CTC ≥5 was associated with shorter survival of patients with intrahepatic CCA (HR, 4.2; 95% CI: 1.1‐14.1; P  = 0.04). Conclusion : CTCs were associated with more‐aggressive tumor characteristics and independently associated with survival in patients with CCA. Assessment of CTCs may be useful for identifying CCA patients at risk of early mortality. (H epatology 2016;63:148–158)

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here